11/14
09:05 am
ino
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at UBS Group AG.
Medium
Report
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at UBS Group AG.
11/4
07:21 am
ino
Inovio Pharmaceuticals (NASDAQ:INO) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Inovio Pharmaceuticals (NASDAQ:INO) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..